Dendreon Information
Contact top employees from
Dendreon
Summary
Dendreon is a private company that has been in the industry for 33 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Jason O'Neill. Its headquarters is located at Seal Beach, California, USA. The number of employees ranges from 500 to 1.0K. The annual revenue of Dendreon varies between 100M and 500M. Total funding of the company - $90M. To connect with Dendreon employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
500-1000 employees
Specialties
Oncology, Cancer Treatment, Immunotherapy, Cellular Immunotherapy, Urology, CMO, Contract Manufacturing
SIC Code
2836
DMA Code
Los Angeles Metropolitan Area
Founded
1992
Estimated Annual Revenue
$100M - 500M
Operating Status
Subsidiary
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2008 | Public Company | 100 - 250 | 66.4M | $290.6M | |
| 2019 | Privately Held | 25 - 100 | 5.1M | $174M | |
| 2017 | Privately Held | 25 - 100 | 4.5M | $9.4M | |
| 2009 | Public Company | 1.0K - 5.0K | 45M | $634.9M | |
| 1979 | Public Company | 250 - 500 | 6.5M | $296.4M | |
| 2013 | Public Company | 1.0K - 5.0K | 106M | $1.5B | |
| 1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
| 2013 | Public Company | 100 - 250 | 89.2M | $204.8M | |
| 1996 | Public Company | 100K - 9.9M | 50.4B | $0 | |
| 1994 | Public Company | 200-500 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Ex-employees switched to
Length of Employment
Employee tenure at Dendreon shows a diverse range of experience levels:
2% have been with the company for less than 1 year3% for 1–2 years8% for 3–4 years9% for 5–7 years11% for 8–10 years67% have over 11 years of service at DendreonEx-employees positions
In Company
In New Company
Contact top employees from
Dendreon
Patrick Stinson
Corporate Account Director-Southeast
Samuel Howard
Sr Program Manager
Ray Passage
Data Integrator
Clifton Poarch
Supervisor
Jennifer Wilcoxson
Quality Assurance Analyst II
Tiffany Decuir
Microbiology Supervisor
Pete Bolin
Director of Business Intelligence and Analytics
Doug Schaumburg
Strategic Account Manager - South Central Region
AISSA PACTOL
Senior Manager, Pharmacovigilance
Kay Ditzenberger
Strategic Account Manager
Margaret Warner
Director Clinical Operations
Edward Dean
Western US Director of Sales
Tami Owens
Strategic Account Manager
Whitney Walters
Oncology Strategic Account Manager
Hector Cortez
Supervisor, Manufacturing
Raul Garcia
Cell culture specialst
Anthony Bryant
Technology Analyst
Jason Fredrickson
Sr. Apheresis Account Manager
Michelle Kelch
Director, Apheresis Operations
Julia Suraci
Senior Salesforce Administrator
Kelly Walsh
Director of Pharmacovigilance
Ramon Alvarado
Supervisor QC Bioassay
Trish Kiely
Nurse Patient Manager
Andy Winecoff
Regional Sales Director
Kurt Brushaber
Senior Director , National Market Acess, Reimbursement & Trade
Helen Wilfehrt
Director in Medical Affairs (Real World Evidence and Scientific Communications)
Similar Companies
FAQ
Dendreon operates in the Biotechnology industries. More details can be found on the official website: dendreon.com.
The headquarters of Dendreon are located in Seal Beach, United States.
The current CEO of Dendreon is Jason O'Neill
You can contact Dendreon by phone at 877-256-4545.
Dendreon currently employs 500-1000 people.
Dendreon's revenue is approximately 272M.
Well-known competitors of Dendreon include CytomX Therapeutics, Pyxis Oncology, Navrogen and Kite Pharma.
